BRIEF-Sol Gel Technologies Sees IPO Of 5 Mln Ordinary Shares

* SOL GEL TECHNOLOGIES LTD SAYS INTENDS TO USE ABOUT $26.0 MILLION OF IPO PROCEEDS TO FUND PLANNED PHASE III CLINICAL TRIALS FOR TWIN FOR TREATMENT OF ACNE

* SOL GEL TECHNOLOGIES-INTENDS TO USE ABOUT $20 MILLION OF IPO PROCEEDS TO FUND PLANNED PHASE III CLINICAL TRIALS FOR VERED FOR TREATMENT OF SUBTYPE II ROSACEA Source text : (bit.ly/2n0Ee1C) Further company coverage: